Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor.
about
Biomedical applications of glycosylphosphatidylinositol-anchored proteinsFurther characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophilsImpaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuriaConstruction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytesIsolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuriaAIDS-associated mycoplasmas possess phospholipases C in the membraneDifferential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria.Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylation.Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein.Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genesCorrelation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3.Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.Effect of lengthening lymphocyte function-associated antigen 3 on adhesion to CD2.Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cells.Novel applications for glycosylphosphatidylinositol-anchored proteins in pharmaceutical and industrial biotechnology.Accessory cell signals involved in T-cell activation.Leucocyte adhesion to cells. Molecular basis, physiological relevance, and abnormalities.Properties of exogenously added GPI-anchored proteins following their incorporation into cells.Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.Membrane-associated proteins regulating the complement system: functions and deficiencies.Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype.Cancer vaccine development: designing tumor cells for greater immunogenicity.Requirement for both the CD3/T cell receptor complex and the CD2/lymphocyte function-associated antigen-3 adhesion system in monocyte-independent T cell activation by oxidized erythrocytes.Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
P2860
Q27468625-D5DC4127-D2F1-4359-AA41-38EAEC2D5D7AQ28188222-C44B31C9-41C5-49F0-B112-493716B6D6E6Q33611200-03A8CD05-688F-4F7C-B924-51FE9F204672Q34027192-D954DE2B-A547-4A4C-9BFD-DE80882021C9Q34174832-3553A202-CD63-431E-B6DA-2ED436002548Q34217447-B8EE5933-9D4E-4D1E-AD4C-DFC7EB9E1024Q34239336-71E0E837-AFC9-4941-B1D1-0A8C6EBC4C74Q34576112-A5967C4A-666E-40C1-BF3C-4EA2EF187735Q34578218-6781E770-6CC4-434B-97A2-A8377D4D6F9DQ35446631-EC3478BD-223D-4722-B137-364B4D720D69Q35600502-AA8184EA-1697-489F-8648-ED5E1EF1BC53Q36207818-77302C46-C26E-4E7A-A20D-8DDD50496048Q36263963-5EA01F13-0465-4C96-A3C5-096F6EA5B356Q36347262-E9834289-B9AC-483C-BD22-0842849B4C23Q36354016-E9F78D77-E13A-4E82-A824-3EC7596137E4Q36355954-C23C5A8E-BCEF-4EEA-9036-82BBA91F91E3Q36355976-11A214E1-97F9-4B84-906E-70C967AC6779Q36695249-23723E75-9C9B-4D54-B7EB-9C998CB11FE2Q37370407-DBCC5312-A23B-4AAE-8D93-9B9272630F93Q37496518-0F6BBD4C-5160-4A91-BE72-523BFAB727E4Q37854052-1743E12E-33D2-426D-9E33-D03C1EBDAB80Q37863466-07366E7E-CBD0-44A6-B9C4-BB8F815A2086Q38205733-20A0E5BD-9748-416B-BC5F-C0DDC5EA80A9Q38492256-16E3FA76-1E17-48C7-9C88-AF622839A7E8Q40336892-C1A1D0ED-C827-48D7-95EA-F12EB688B3C7Q40488634-3FE53BF5-DCAB-442B-896A-937994A86441Q42163220-4D9E16B9-1936-4D19-8FF8-5452DA13BF75Q42384053-A45B9955-2389-479F-9239-69F0BB1F2AE1Q45062018-0EEAE273-127F-4515-A1FD-7ABE09F94FF4Q47232440-6F2E2A7E-E8A4-4664-8E14-F0F06E49C57D
P2860
Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@ast
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@en
type
label
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@ast
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@en
prefLabel
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@ast
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@en
P2093
P2860
P356
P1476
Deficiency of lymphocyte funct ...... tidylinositol membrane anchor.
@en
P2093
P2860
P304
P356
10.1084/JEM.166.4.1011
P407
P577
1987-10-01T00:00:00Z